NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/25/2023
Back to search
Official data from USPTO
MG OSTEOINJECT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
MG OSTEOINJECT
ST13
US500000090779093Class
10
Filing
90779093
Registration
7037983
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/25/2023
Classification
Registered
Trademark type
Word
Nice classes
10
Filing date
06/17/2021
Registration date
04/25/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/25/2023
Last transaction
04/25/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/16/2021
First use in commerce
08/16/2021
Drawing code
4
Owner type
03
Owner location
Colleyville, TX, US
Examiner
DWYER, JOHN D
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Bone Solutions, Inc.
Representatives
Jordan Joseph Pringle MCDONNELL BOEHNEN HULBERT AND BERGHOFF
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Bio-adhesive bone substitute for medical and dental usemagnesium-based bone void fillers consisting of synthetic materials for medical purposes
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/25/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/21/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/18/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/08/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/07/2023
EX1G
SOU EXTENSION 1 GRANTED
03/07/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/07/2023
IUAF
USE AMENDMENT FILED
02/22/2023
EXT1
SOU EXTENSION 1 FILED
02/22/2023
EEXT
SOU TEAS EXTENSION RECEIVED
02/22/2023
EISU
TEAS STATEMENT OF USE RECEIVED
02/22/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/30/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/05/2022
PUBO
PUBLISHED FOR OPPOSITION
07/05/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/15/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/28/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/27/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/26/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/26/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/29/2021
GNRT
NON-FINAL ACTION E-MAILED
11/29/2021
CNRT
NON-FINAL ACTION WRITTEN
11/29/2021
DOCK
ASSIGNED TO EXAMINER
11/27/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/02/2021
NWAP
NEW APPLICATION ENTERED
06/21/2021
Continuous trademark protection
Get notified about every new filing that threatens MG OSTEOINJECT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.